Showing results (61-70 of 82) with videos related to
Sort By:
Pageof 9
Blood|June 20, 2026
Ibrutinib in early stage CLL: Genetic risk factors and treatment outcome in the GCLLSG CLL12 trialArmin Riecke, Sandra Robrecht, Deyan Yordanov Yosifov, et al.Physical Review Letters|May 1, 2012
Explosions of xenon clusters in ultraintense femtosecond x-ray pulses from the LCLS free electron laserH Thomas, A Helal, K Hoffmann, et al.Blood|May 7, 2014
Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemiaNatali Pflug, Jasmin Bahlo, Tait D Shanafelt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2021
The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer AgentsPauline Dürr, Katja Schlichtig, Carolin Kelz, et al.The Review of Scientific Instruments|November 7, 2012
South pole bang-time diagnostic on the National Ignition Facility (invited)D H Edgell, D K Bradley, E J Bond, et al.The Review of Scientific Instruments|December 3, 2016
High-resolution measurements of the DT neutron spectrum using new CD foils in the Magnetic Recoil neutron Spectrometer (MRS) on the National Ignition FacilityM Gatu Johnson, J A Frenje, R M Bionta, et al.The Lancet. Oncology|March 1, 2011
Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trialLuca Gianni, Urania Dafni, Richard D Gelber, et al.Leukemia|February 12, 2020
Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study groupManuela A Hoechstetter, Raymonde Busch, Barbara Eichhorst, et al.Blood|September 4, 2025
Acalabrutinib treatment for older (≥80 years old) and/or frail patients with CLL: primary end point analysis of the CLL-Frail trialFlorian Simon, Rudy Ligtvoet, Jan-Paul Bohn, et al.Blood|April 29, 2015
Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IVSusanne Saussele, Marie-Paloma Krauss, Rüdiger Hehlmann, et al.Pageof 9